Atogepant
Modify Date: 2024-01-02 19:01:46
Atogepant structure
|
Common Name | Atogepant | ||
|---|---|---|---|---|
| CAS Number | 1374248-81-3 | Molecular Weight | 603.515 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 693.9±55.0 °C at 760 mmHg | |
| Molecular Formula | C29H23F6N5O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 373.5±31.5 °C | |
Use of AtogepantA potent, selective and orally available CGRP receptor antagonist for the prevention of migraine. Migraine Phase 3 Clinical |
| Name | atogepant |
|---|---|
| Synonym | More Synonyms |
| Description | A potent, selective and orally available CGRP receptor antagonist for the prevention of migraine. Migraine Phase 3 Clinical |
|---|---|
| References | References View Related Products by Target CGRP Receptor Migraine |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 693.9±55.0 °C at 760 mmHg |
| Molecular Formula | C29H23F6N5O3 |
| Molecular Weight | 603.515 |
| Flash Point | 373.5±31.5 °C |
| Exact Mass | 603.170532 |
| LogP | 4.37 |
| Vapour Pressure | 0.0±2.2 mmHg at 25°C |
| Index of Refraction | 1.624 |
| atogepant |
| 7CRV8RR151 |
| atogepantum |
| (6S)-N-[(3S,5S,6R)-6-Methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)-3-piperidinyl]-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxamide |
| Spiro[6H-cyclopenta[b]pyridine-6,3'-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide, 1',2',5,7-tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)-3-piperidinyl]-2'-oxo-, (6S)- |